Portfolio Companies 2026 for Pfizer: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Pfizer accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $13B. The median disclosed raise is $130M, and the largest is Metsera at $10B, ahead of Trillium Therapeutics ($2.3B) and Genuine Biotech ($220M).
The names that recur most often on these portfolio cap tables are Pfizer (13 companies), Novartis Venture Fund (2 companies), Novo Ventures (2 companies), Roche Venture Fund (2 companies), Merck (2 companies), Verdiva Bio Dev Limited (1 company). By latest disclosed round, the market skews Series B (5), IPO (4), Series A (3), Seed (1).
Companies tracked: 13
Disclosed funding total: $13B across 13 companies
Median disclosed raise: $130M
Largest raise: Metsera — $10B
Stage mix: Series B 5 · IPO 4 · Series A 3 · Seed 1
